SCHEMBL25880372

SCHEMBL25880372

Cc1cc(C)c(-c2ccc3c4c2c2ccccc2n4c2ccc(-c4c(C)cc(C)cc4C)c4c5ccccc5n3c42)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
NQO2 P16083 1/20 0.35
NTRK1 P04629 1/20 0.33
CHEK1 O14757 1/20 0.33
PDK2 Q15119 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
FTO Q9C0B1 1/20 0.33
ABCB1 P08183 6/20 0.31
CRHR1 P34998 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 1/20 0.31
GAA P10253 1/20 0.31
CCNE2 O96020 1/20 0.30
CDK4 P11802 1/20 0.30
PRKACA P17612 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20857931 0.87 CYP1A2 (0.37) CYP1A2CYP2A6KDM4EMAPTNQO2
SCHEMBL25880428 0.85 DRD2 (0.30)
SCHEMBL25880370 0.83 BRD9 (0.42) CYP1A2CYP2A6KDM4EMAPTNQO2
SCHEMBL24601592 0.82 CYP1A2 (0.38) CYP1A2CYP2A6KDM4EMAPTNQO2
SCHEMBL25880355 0.80 MAPT (0.41) KDM4EMAPTNQO2NTRK1CHEK1
SCHEMBL24601506 0.79 FLT3 (0.35) CYP1A2CYP2A6KDM4EMAPTNTRK1
SCHEMBL24601459 0.79 CYP1A2 (0.40) CYP1A2CYP2A6KDM4EMAPTNQO2
SCHEMBL24601480 0.78 FLT3 (0.34) CYP1A2CYP2A6KDM4EMAPTNTRK1
SCHEMBL24601615 0.78 CYP1A2 (0.39) CYP1A2CYP2A6KDM4EMAPTNQO2
SCHEMBL25880361 0.78 NPC1 (0.42) MAPTNTRK1CHEK1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219497-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2023-08-02 EP disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 CYP1A2 21/4885CYP2A6 334/4885KDM4E 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.